PDI, Inc., a Top BioPharmaceutical Contract Sales Organization, Selects Veeva Systems, Inc.’ Multi-tenant SaaS CRM System

PLEASANTON, Calif.--(BUSINESS WIRE)--PDI, Inc. (Nasdaq: PDII), a leading provider of sales and marketing support to U.S. pharmaceutical companies, selected Veeva System’s VBioPharma CRM Primary Care and Special Care Editions, VMobile, and VInsights – all part of the Veeva CRM suite of multi-tenant SaaS applications. This marks PDI’s continued commitment to the technology advances in the world of cloud computing where business spending on SaaS/Cloud applications is expected to rise 22% this year to $9.6 billion, according to Gartner [http://blogs.zdnet.com/BTL/?p=17662]. All of PDI’s managed sales forces across various dedicated sales teams plus its ‘pulsing’ sales teams will go live with Veeva CRM by the end of 2009 to completely replace its former sales force automation system.

MORE ON THIS TOPIC